Biofrontera (BFRI) Change in Account Payables (2024 - 2025)

Biofrontera (BFRI) recorded quarterly Change in Account Payables of $3.4 million in Q4 2025, up 155.02% quarter-over-quarter from $1.3 million in Q3 2025, and up 2062.57% on a YoY basis from $155185.5 in Q4 2024.

Biofrontera (BFRI) Change in Account Payables (2024 - 2025) Analysis & Trends

Biofrontera's Change in Account Payables history runs 2 years deep, the most recent figure standing at $3.4 million for Q4 2025.

  • In Q4 2025, Change in Account Payables rose 2062.57% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at -$2000.0 (up 99.86% YoY), while the FY2025 annual figure was -$2000.0, up 99.86% from the prior year.
  • Change in Account Payables was $3.4 million for Q4 2025 at Biofrontera, up from $1.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q4 2025 to a low of -$6.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn -
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 62.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn -
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 190,000.00
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 562,000.00
10 Biofrontera 8.81 Mn 2.40 Mn 14.09 Mn 3.36 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.36 Mn
Dec 31, 2025 3.36 Mn
Sep 30, 2025 1.32 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 -6.12 Mn
Jun 30, 2025 -6.12 Mn
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 -171,000.00
Dec 31, 2024 -171,000.00
Sep 30, 2024 2.16 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 -2.85 Mn
Jun 30, 2024 -2.85 Mn
Mar 31, 2024 -590,000.00
Mar 31, 2024 -590,000.00